On the other hand, treatment with ibrutinib did not inhibit the capacity of Wnt5a to induce CLL-cell phosphorylation of NF-κB-p65 (Fig. 5D). This evidence concerns the gene WNT5A and B-cell chronic lymphocytic leukemia.